相关实验视频

Updated: Jun 15, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

社区获得的呼吸道病毒对实体器官移植患者的临床影响

Supriya Singh¹, Enambir Josan², Christopher Kovacs³

¹Department of Infectious Diseases, The Cleveland Clinic Foundation, Cleveland, Ohio; Department of Infectious Diseases, The University of Tennessee Medical Center, Knoxville, Tennessee.

Transplantation proceedings

|August 24, 2024

概括

社区获得的呼吸道病毒 (CARV) 对实体器官移植接受者构成重大风险,导致发病率和死亡率增加. 早期诊断和治疗对于改善这种脆弱患者群体的治疗结果至关重要.

科学领域:

传染性疾病传染性疾病
移植医学移植医学移植医学
关键护理医学关键护理医学

背景情况:

社区获得的呼吸道病毒 (CARV) 与固体器官移植 (SOT) 受体的不良结果有关.
研究的结果包括呼吸支,住院时间,ICU入院,类固醇使用和30天死亡率.
接受SOT的患者通常免疫力低下,因此对感染的易感性增加.

研究的目的:

为了评估SOT接受者入院患有CARV感染的临床结果.
识别风险因素和与预后不佳相关的特定病毒病原体.
强调需要及时诊断和管理策略的需要.

主要方法:

从单个中心对电子健康记录的回顾性审查.
从2014年1月1日至2019年12月31日期间收集的数据.
纳入标准:SOT接收者为CARVs.阳性.

主要成果:

确定了23名具有CARV的SOT接受者 (平均年龄为60岁,70%为男性).
常见的CARV包括鼻病毒 (48%) 和偏流感 (29%).
结果:6名患者需要ICU,8名患者需要氧气支持,1年内35%的死亡率;5名活检显示急性细胞排斥.

结论:

接受SOT的人面临CARV感染的高风险,导致显著的发病率和死亡率.
这项研究强调了及时诊断和针对性治疗SOT患者的CARV的重要性.
对这一群体进行特定干预的进一步研究是有必要的.

更多相关视频

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-I

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

Acute Respiratory Failure-III

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...